Paper

Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.

Published Dec 1, 2008 · Ticyana Moralez da Silva, R. Munhoz, C. Alvarez

Journal of affective disorders

188

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCTHighly Cited

Study Snapshot

Omega-3 fatty acid supplementation in Parkinson's disease patients with depression showed improvement in depressive symptoms, suggesting its potential as an adjuvant therapy.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.

References

Citations